Scorpiones, Scolopendra and Gekko Inhibit Lung Cancer Growth and Metastasis by Ameliorating Hypoxic Tumor

Qi-Yuan Mao1, Xue-Qian Wang1, Fei Lin1

  • 1Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.

Abstract

Insights

Traditional Chinese medicines Buthus martensii karsch (Scorpiones), Scolopendra subspinipes mutilans L. Koch (Scolopendra), and Gekko gecko (Gekko) show promise in treating lung cancer. These agents ameliorate the hypoxic tumor microenvironment and inhibit cancer growth by regulating the PI3K/AKT/mTOR/HIF-1α pathway.

Area of Science:

  • Pharmacology and Toxicology
  • Oncology
  • Molecular Biology

Background:

  • The tumor microenvironment, particularly hypoxia, plays a critical role in lung cancer progression and metastasis.
  • The phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin/hypoxia-inducible factor-1α (PI3K/AKT/mTOR/HIF-1α) signaling pathway is frequently dysregulated in cancer, promoting tumor growth and survival.
  • Traditional Chinese medicines are increasingly explored for their therapeutic potential in cancer treatment.

Purpose of the Study:

  • To investigate the effects of Buthus martensii karsch (Scorpiones), Scolopendra subspinipes mutilans L. Koch (Scolopendra), and Gekko gecko (Gekko) on lung cancer.
  • To determine if these agents can ameliorate the hypoxic tumor microenvironment and inhibit lung cancer growth and metastasis.
  • To elucidate the role of the PI3K/AKT/mTOR/HIF-1α signaling pathway in the observed effects.

Main Methods:

  • Lung cancer models were established in male C57BL/6J mice using LL/2-luc-M38 cells.
  • Mice were treated with Scorpiones, Scolopendra, and Gekko extracts, with rapamycin and cyclophosphamide as positive controls.
  • Tumor growth, metastasis, HIF-1α and CD31 expression, microvessel density (MVD), and key proteins and factors in the PI3K/AKT/mTOR/HIF-1α pathway (including bFGF, TGF-β1, VEGF) were analyzed.

Main Results:

  • Scorpiones, Scolopendra, and Gekko significantly prolonged survival and inhibited lung cancer metastasis and HIF-1α expression.
  • These agents suppressed the phosphorylation of AKT and p70S6K, key components of the PI3K/AKT/mTOR pathway.
  • Treatment reduced CD31 expression, MVD, and levels of bFGF, TGF-β1, and VEGF, indicating reduced angiogenesis and altered tumor microenvironment.

Conclusions:

  • Buthus martensii karsch (Scorpiones), Scolopendra subspinipes mutilans L. Koch (Scolopendra), and Gekko gecko (Gekko) demonstrate significant anti-lung cancer effects.
  • These beneficial effects are mediated by the amelioration of the hypoxic tumor microenvironment through the regulation of the PI3K/AKT/mTOR/HIF-1α signaling pathway.
  • The findings support the potential of these traditional medicines as complementary therapies for lung cancer.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.8K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K